?Thanks to buzzy results and popularity among celebrities, there\’s a big spike in demand for GLP-1 drugs, such as Ozempic and Wegovy, as a tool to help people shed pounds. The injectable medications, originally prescribed for diabetes management, have also shown promising results for weight loss. That demand is creating an important decision point for …
Continue reading “Employers’ New Decision Point: Whether to Cover Expensive Weight Loss Drugs”
